These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer. Powell JL; Kirchner AB J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541 [No Abstract] [Full Text] [Related]
3. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters. Henretta MS; Anderson CL; Angle JF; Duska LR Gynecol Oncol; 2011 Nov; 123(2):342-5. PubMed ID: 21840583 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits. Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951 [TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications. Walton LA; Yadusky A; Rubinstein L Int J Radiat Oncol Biol Phys; 1991 May; 20(5):939-44. PubMed ID: 2022522 [TBL] [Abstract][Full Text] [Related]
6. Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer. Carlson JA; Jose B; Sharma SC; Osborne RP Am J Obstet Gynecol; 1983 Dec; 147(7):840-1. PubMed ID: 6650612 [No Abstract] [Full Text] [Related]
8. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer. Powell JL; Burrell MO; Kirchner AB South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895 [TBL] [Abstract][Full Text] [Related]
9. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer. Sharma SC; Osborne RP; Jose B; Carlson JA Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947 [No Abstract] [Full Text] [Related]
10. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma. Wilkinson RH J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ; J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800 [TBL] [Abstract][Full Text] [Related]
12. Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report. Neutze J; Van Nostrand D; Major W Clin Nucl Med; 1985 Nov; 10(11):777-9. PubMed ID: 4075668 [TBL] [Abstract][Full Text] [Related]
13. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma. Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251 [TBL] [Abstract][Full Text] [Related]
14. [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature]. Wolff JP; Burini GA Minerva Ginecol; 1985; 37(7-8):407-13. PubMed ID: 3906441 [No Abstract] [Full Text] [Related]
15. Update on the role of radiotherapy in ovarian cancer. Lanciano R; Reddy S; Corn B; Randall M Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849 [No Abstract] [Full Text] [Related]
16. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients. Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466 [TBL] [Abstract][Full Text] [Related]
17. Peripherally inserted central catheters in infants and children. Dubois J; Garel L; Tapiero B; Dubé J; Laframboise S; David M Radiology; 1997 Sep; 204(3):622-6. PubMed ID: 9280235 [TBL] [Abstract][Full Text] [Related]
18. Chromic phosphate therapy in carcinoma of the ovary. Goodman A; Bornstein L; Ball H; Smith DM; Bankoff M J Am Coll Surg; 1994 Oct; 179(4):401-6. PubMed ID: 7921388 [TBL] [Abstract][Full Text] [Related]
19. Sonographically guided venous puncture and fluoroscopically guided placement of tunneled, large-bore central venous catheters for bone marrow transplantation-high success rates and low complication rates. Gebauer B; Teichgräber UM; Werk M; Beck A; Wagner HJ Support Care Cancer; 2008 Aug; 16(8):897-904. PubMed ID: 18197436 [TBL] [Abstract][Full Text] [Related]